The speaker will present on three QIMR Berghofer-led initiatives:
1. The Pathways Study: Interviewed over 200 participants about their journey to diagnosis. Speaker will talk about the early symptoms, performance of 3 different decision support tools, and pathways to diagnosis.
2. The Panlink Study: Present the results of modelling to develop a risk prediction tool for people with new-onset diagnosis, and variability in access to surgical care.
3. I will describe a new pilot study, focused on screening people with new-onset diabetes